Acute Lymphoblastic Leukemia (ALL), Adult
2 clinical trials · Condition
◉ Watch Acute Lymphoblastic Leukemia (ALL), Adult
| Record | Firm | Date |
|---|---|---|
| Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies (NCT07312630) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2025-09-25 |
| Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies (NCT06398457) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-09-19 |
Track Acute Lymphoblastic Leukemia (ALL), Adult automatically
Every clearance here is in the API, with alerts when new ones post.